420 with CNW — Deadline Looms for the FDA to Publish Cannabinoids List
Federal hemp regulations are set to shift dramatically in nine months, a change that industry leaders warn could effectively outlaw most consumable cannabinoid products. In the meantime, the FDA faces a looming deadline to provide guidance that could shape the future of hemp policy. Last year, President Donald Trump signed an appropriations bill that included a provision reversing the 2018 Farm Bill’s legalization of certain hemp products. While the bill reinstates restrictions on these products starting Nov. 1, it also instructs the FDA and other agencies to compile detailed lists of cannabis-derived compounds. The law tasked the FDA with producing three lists within 90 days of enactment: all cannabinoids the…

















